D-Dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study

Clinical and Experimental Medicine

Volumn 1, Issue 4, 2001, Pages 219-224

  Prisco, D ^a   Antonucci, E ^a   Fedi, S ^a   Margheri, M ^a   Giglioli, C ^a   Comeglio, M ^a   Lombardi, A ^a   Chioccioli, M ^a   Abbate, R ^a   Gensini, G F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Clinical recurrence; D Dimer; Percutaneous transluminal angioplasty; Plasminogen activator inhibitor 1; Primary revascularization; Stent

Indexed keywords

D DIMER; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; EVALUATION; FEMALE; FIBRIN FORMATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; RECURRENT DISEASE; RESTENOSIS; STENT; VASCULARIZATION;

EID: 18344392053     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s102380100006     Document Type: Article

References (27)

1. Plasminogen-activator inhibitor type 1 and coronary artery disease
2. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol: Results from Angina Prognosis Study in Stockholm
3. Progression of coronary artery disease in young male post-infarction patients linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function
4. Impairment of early fibrinolytic activation after PTCA: A mechanism for restenosis-related clinical recurrence?
5. Post-procedural PAI-1 activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective balloon PTCA
6. Coronary artery stents
7. Nomenclature and criteria for diagnosis of ischemic heart disease
8. Unstable angina: A classification
9. Transluminal treatment of atherosclerotic obstruction: Description of a new technique and a preliminary report of its application
10. The thrombolysis in myocardial infarction (TIMI) trial: Phase one findings
11. Quantitative coronary angiography: Estimation of dimension hemodynamic resistance, atheroma mass of coronary artery lesions using arteriogram and digital computation
12. Coronary vasodilatation by nitrates is not mediated by the prostaglandin system: An angiographic and hemodynamic study
13. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma
14. Exercise standards. A statement for healthcare professionals from the American Heart Association
15. Advances in coronary angioplasty
16. Impaired fibrinolysis early after PTCA is associated with restenosis
17. Thrombin-stimulated events in cultured vascular smooth muscle cells
18. The role of platelets, thrombin, and hyperplasia in restenosis after coronary angioplasty
19. Fibrin and fibrinogen related antigens in patients with stable and unstable coronary artery disease
20. The platelet and plasma pools of plasminogen activator inhibitor (PAI-1) vary independently in disease
21. Role of thrombin in arterial thrombosis: Implications for therapy
22. The pathogenesis of atherosclerosis - An update
23. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events
24. Hemostatic risk factors for atherothrombotic disease: An epidemiologic view
25. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men
26. Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention
27. Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty